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Abstract
Approaches for manipulating cell type-specific gene expression during development depend on the identification of novel
genetic tools. Here, we report the generation of a transgenic mouse line that utilizes Vsx2 upstream sequences to direct Cre
recombinase to developing retinal bipolar cells. In contrast to the endogenous Vsx2 expression pattern, transgene
expression was not detected in proliferating retinal progenitor cells and was restricted to post-mitotic bipolar cells. Cre
immunolabeling was detected in rod bipolar cells and a subset of ON and OFF cone bipolar cells. Expression was first
observed at postnatal day 3 and was detectable between 24 hours and 36 hours after the last S-phase of the cell cycle. The
appearance of Cre-immunolabeled cells preceded the expression of bipolar cell type-specific markers such as PKCa and
Cabp5 suggesting that transgene expression is initiated prior to terminal differentiation. In the presence of a constitutive
conditional reporter transgene, reporter fluorescence was detected in Cre-expressing bipolar cells in the mature retina as
expected, but was also observed in Cre-negative Type 2 bipolar cells and occasionally in Cre-negative photoreceptor cells.
Together these findings reveal a new transgenic tool for directing gene expression to post-mitotic retinal precursors that are
mostly committed to a bipolar cell fate.
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Introduction
The successful progression of retinal development requires that
complementary mechanisms of self-renewal and cell differentiation
befinelyregulatedwithinretinalprogenitor cells(RPCs). A variety of
intrinsic, trans-activating proteins regulate this process and include
members of the homeodomain family of transcription factors.
The Vsx2/Chx10 (herein referred to asVsx2) transcriptionfactor
is a highly conserved paired-like homeodomain protein that is
expressed in a number of developing central nervous system
structures, including spinal cord, ventral hindbrain, and retina [1].
Essential functions of Vsx2 orthologues have been demonstrated in
species ranging from C. elegans [2], teleost [3,4,5], chick [6] and
humans[7]. Vsx2isexpressedinRPCsengaged inthecellcycle,and
is retained in bipolar interneurons [8], and a subset of Mu ¨ller glia
[9]. Vsx2 loss-of-function mutations lead to microphthalmia in mice
[8] and humans [7]. In addition, there is a specific loss in the
specification of bipolar interneurons in the mouse Vsx2 loss-of-
function mutant, which highlights the evolutionary conserved role
of Vsx2 in sensory interneuron development [8,10,11]. Recent
evidence has revealed that Vsx2 function shifts from that of cell cycle
maintenance in early phases of RPC activity, to that of bipolar cell
specification and repression of photoreceptor production during
later phases of retinogenesis [12]. The highly conserved and
pleiotropic function of the Vsx2 gene, as well as its requirement for
human ocular development make it a strong focus of retinal
research.
A number of studies have examined the promoter sequences
and upstream regulatory elements of Vsx2 [9,13,14]. One such
study utilized a bacterial artificial chromosome (BAC) harbouring
,100 kb Vsx2 upstream sequence to generate transgenic reporter
mice [9]. Reporter expression in this transgenic mouse was
mosaic, but recapitulated putative Vsx2 protein localization in
RPCs, differentiated bipolar cells and Mu ¨ller glia. More detailed
analyses of upstream regulatory elements identified a 22 bp
sequence located within a 3 kb upstream region required for Vsx2
expression postnatally [13], and a 164 bp sequence located
,19 kb upstream of the Vsx2 start site that is sufficient to drive
bipolar cell-specific expression [15]. Therefore it appears that
distinct Vsx2 upstream regulatory sequences are able to direct
accurate retinal expression of Vsx2 in a spatiotemporal context. In
this report, we describe the generation of a novel transgenic mouse
line utilizing Vsx2 upstream sequences to direct the expression of
Cre recombinase. Vsx2-5.3-PRE-Cre mice exhibit highly restricted
Cre expression that partially overlaps with the temporal and cell
type-specific expression of putative Vsx2. Birth dating experiments
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postmitotic bipolar cells and not detectable in RPCs or Mu ¨ller glia.
This transgene also identifies what appears to be transient or
below detectable levels of activity of the Vsx2 transgene in either
bipolar/photoreceptor precursors or photoreceptors. Together,
these data reveal a novel transgenic tool that can be used for the
conditional targeting of post-mitotic bipolar cells.
Materials and Methods
Generation of Vsx2-5.3-PRE-Cre mice
A 5.3 kb region upstream of murine Vsx2 that extends into
the 59 UTR region up to the Vsx2 start codon was cloned into
the NotIa n dSacII sites of pBluescript (Stratagene/Agilent,
Santa Clara, CA). A 2 kb putative retinal enhancer (PRE) region
within the 59 breakpoint in the Vsx2 or-2J (ocular retardation-2J)
allele and containing the 164 bp bipolar enhancer region [15]
was amplified and cloned 59 of the 5.3 kb upstream sequence.
Cre recombinase was cloned downstream of the 5.3 kb Vsx2
region and was followed by an SV40 poly adenylation sequence.
Transgenic mice were generated in a C576C3H strain
background offspring were identified by PCR genotyping of the
Cre insert using either ear clip or tail genomic DNA preparations.
Primers sequences used were as follows: Cre-forward–59-C C C
ATG GTC TTC TTC TGC AT – 39; Cre-reverse – 59-C C A
TGA GTG AAC GAA CCT GG – 39.
Animal Husbandry and Breeding
All experimental procedures performed on mice as well as
housing of mice was done with the approval of the University
of Victoria Animal Care Committee (Protocol 2008-013)
following standards described by the Canadian Council for
Animal Care. Vsx2-5.3-PRE-Cre mice were maintained by breed-
ing founder mice with non-transgenic background strains
(129S1 or CD1, The Jackson Laboratory, Bar Harbor ME).
mGluR6:NLS-LacZ mice express a nuclear localized version of b-
galactosidase under the control of the mGluR6 upstream sequence
[16]. Gt(ROSA)26Sor
tm9(CAG-tdTomato)Hze mice (The Jackson Labora-
tory, Stock number 007914) have a loxP-flanked STOP cassette
preventing transcription of a CAG promoter-driven red fluores-
cent protein variant (tdTomato), and was used as a Cre reporter
strain.
Metabolic labeling of proliferating cells and their
progeny
To label cells during the S-phase of mitosis, a single intraperi-
toneal injection of 59-chloro 2-deoxy-uridine (CldU–46 mg/kg,
Sigma-Aldrich, Ontario, Canada) was performed on postnatal pups
rangingfrom P0-P6.Thisdosage and regimen of administrationhas
been shown to consistently label proliferating cells in the central
nervous system [17,18,19]. Preliminary immunocytochemical
assessment confirmed that CldU labeling was restricted to the
nucleus using TO-PROH -3 iodide (1:1000-T-3605, Molecular
Probes, Oregon, USA).
Tissue processing and Immunolabeling
Adult mice were anesthetized and euthanized by cervical
dislocation. Eyes were enucleated, washed in chilled phosphate
buffered saline PBS (pH 7.4) and were fixed either by emersion in
chilled 4% paraformaldehyde (PFA) (Electron Microscopy Sciences,
Hatfield, PA) for25 minutesorovernight at4 deg C.Fixed eyeswere
washed in PBS and cryoprotected in 30% sucrose for 18 hours.
Following blockembedding, serialcryostatsectioning wasperformed
atathicknessof12 mm.Forimmunolabeling,mounted sectionswere
washed in phosphate buffered saline (PBS), permeabilized in 1%
Triton-X 100 for 30 minutes at room temperature, and incubated
with in primary antibody diluted in PBS (Table 1). In the case of
CldU immunolabeling, sections were placed in 2N HCL for 45
minutes at room temperature prior to permeabilization. Sections
were then rinsed and incubated with Alexa-conjugated fluorescent
secondary antibodies (1:500-Invitrogen, ON, Canada) for 1 hour at
room temperature, followed by washing in PBS and mounting in
Immuno-mount (Shandon, PA, USA).
Confocal Microscopy
Immunolabeled sections were imaged using either a Nikon
Eclipse TE-2000-U or a Zeiss LSM700 confocal microscope
equipped with APO TIRF 1.49 oil/DIC objective lenses (20-63X
magnification). Pinhole diameters were maintained at 1 AU and
laser outputs were optimized for individual staining intensities.
Emission spectra were matched to secondary antibodies and
tdTomato spectral characteristics. Orthogonal analysis was used to
ensure co-localization of contrasting subcellular staining domains.
Images were cropped and processed for brightness using Adobe
Photoshop CS3.
Table 1. List of Antibodies.
Antigen Antiserum Source Working dilution
Chx10/Vsx2 sheep anti-Chx10 Exalpha Biologicals (X1180P) 1:500
Vsx1 rabbit anti-Vsx1 RL Chow 1:100
Calbindin D-28k rabbit anti-Calbindin-D-28K Sigma (C 2724) 1:1000
Cabp5 rabbit anti-Cabp5 F. Haeseleer, Department of Ophthalmology, Seattle, WA 1:500
b-Gal rabbit anti-b-Gal ICN, Aurora, OH (55976) 1:20,000
PKCa rabbit anti-PKCa Sigma (P4334) 1:10,000
Bhlhb5 goat anti-b3(E17) Santa Cruz (sc-6045) 1:1000
PKA RIIb mouse anti- PKA RIIb BD science (612550) 1:3,000
Cre recombinase mouse anti Cre Covance (MMS-106) 1:1000
Cre recombinase rabbit anti-Cre Covance (PRB-106c) 1:2000
BrdU (CldU) rat anti-BrdU Accurate Chemical & Scientific 1:500
doi:10.1371/journal.pone.0027145.t001
Bipolar Cell-Specific Transgenic Mouse
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Expression of the Vsx2-5.3-PRE-Cre transgene in mouse
bipolar cells
The Vsx2-5.3-PRE-Cre transgene was generated such that a
5.3 kb upstream region of Vsx2 plus a 1.9 kb region located 18 kb
upstream of the Vsx2 start codon was placed upstream of a Cre-
expressing cDNA cassette (Figure 1A). The 1.9 kb Vsx2 upstream
fragment was originally identified as a potential retinal enhancer
(PRE) as it lies within the breakpoint of the ocular retardation 2J
mutation within a non-coding region that is conserved between
human and mouse (M. Burmeister, pers. comm.). Six lines of
Vsx2-5.3-PRE-Cre mice were generated, all of which carried the
Cre transgene as identified by PCR genotyping (Table 2).
Expression of Cre recombinase, as determined by Cre immuno-
labeling was detected in 4 of these lines (Table 2). In contrast to
the normal expression of Vsx2 in retinal progenitor cells at E14.5
[1], Cre labeling was not detectable in retinas from E14.5 Vsx2-
5.3-PRE-Cre mice (Figure 1B,C). Examination of adult tissue from
all lines revealed that Vsx2-5.3-PRE-Cre retinas exhibited normal
thickness and lamination, and contained robust nuclear localized
Cre immunolabeling within the inner nuclear layer (Figure 1D,E).
The location of Cre-labeling was consistent with the pan-bipolar
expression of Vsx2, and did not extend into the ciliary epithelium
or other non-neuroretinal structures (not shown).
To verify that the Vsx2-5.3-PRE-Cretransgene was expressed in
bipolar cells, we next examined Cre transgene expression in the
mature retina double-immunolabeled for Cre and Vsx2. Co-
immunolabeling of Cre with Vsx2 verified that 80% of Vsx2-
postive nuclei located in the outer inner nuclear layer were Cre-
positive, whereas 100% of Cre labeled nuclei co-labeled with
Vsx2 (Figure 2A–C). As Vsx2 is also weakly expressed in Mu ¨ller
glia [9], we double-labeled retinas with the Mu ¨ller marker Sox9
[20], but were unable to detect co-immunolabeling (Figure 2D–
F). Similarly, co-immunolabeling of sections with Cre and the
horizontal and amacrine cell marker, Calbindin D-28k [21],
verified that Cre was not detectable in these other inner nuclear
layer interneurons (Figure 2G–I). These results show that Vsx2-
5.3-PRE-Cre is not expressed at detectable levels in the embryonic
retina, and is restricted to a large subset of Vsx2-expressing
bipolar cells in the mature retina.
Vsx2-5.3-PRE-Cre is expressed in a large subset of adult
bipolar neurons
To determine the cellular subtype specificity of the Vsx2-5.3-
PRE-Cre transgene expression, we next evaluated Cre immuno-
labeling in combination with panel of bipolar cell markers
(Table 1). At least 11 subtypes of bipolar interneurons can be
identified based on their morphology and distinct gene
expression patterns [22,23,24,25]. Vsx2-5.3-PRE-Cre co-localized
with nearly all PKCa-expressing rod bipolar cells (Figure 3A–C)
and with approximately 50% cells labeled with Cabp5, a marker
of Type 3 OFF, Type 5 ON and rod bipolar cells
[23](Figure 3D–F). To determine whether Vsx2-5.3-PRE-Cre is
absent from all ON bipolar cells, we crossed Vsx2-5.3-PRE-Cre
mice with a transgenic strain of mice expressing a nuclear-
localized version of b-galactosidase under the control of the
mGluR6 9.5 kb upstream region [16], which selectively directs
expression to all ON type bipolar cells [26]. Vsx2-5.3-PRE-Cre
was localized within a large subset of mGluR6:b-galactosidase
immunolabeled-expressing cells (Figure 3G–I, arrows) although
not all mGluR6:b-galactosidase labeled cells were co-labeled for
Cre (Figure 3G–I, black arrowheads). In addition, some Cre-
labeled cells did not label for mGluR6:b-galactosidase (Figure 3G–
I, white arrowheads) suggesting that they were OFF bipolar cell
types. We found no examples of Cre labeling in Bhlhb5-
expressing Type 2 OFF bipolar cells (Figure 3J–L), however we
did observe co-labeling with PKARIIb (Figure 3M–O, arrows),
which labels Type 3b OFF bipolar cells[24]. These observations
indicate that Vsx2-5.3-PRE-Cre is detectable in a broad subset of
Figure 1. Vsx2-5.3-PRE-Cre is expressed in the postnatal and adult retinal inner nuclear layer. (A) The pLac-Vsx5.3-PRE transgene construct
contains a 1.9 kb Vsx2 upstream conserved region (UCR), cloned 59 of a 5.4 kb genomic fragment containing the 59UTR of Vsx2 and followed by a Cre
recombinase encoding fragment. Abbreviations UTR: untranslated region; SV40 pA: SV40 polyadenylation signal. Cre recombinase immunolabeling is
not detected in either the neuroblastic layer (NBL) or ganglion cell layer (GCL) of E14.5 retinas (B, C), but is detected in the outer portion of the inner
nuclear layer (INL) in adult mice (D, E). Arrowheads in (D) indicate non-specific labelling of blood vessels by mouse anti-Cre antibody. Scale bar
=50mm.
doi:10.1371/journal.pone.0027145.g001
Bipolar Cell-Specific Transgenic Mouse
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OFF bipolar cells and a subset of ON bipolar cells.
Onset of Vsx2-5.3-PRE-Cre transgene expression
In contrast to the endogenous expression pattern of Vsx2 [1],
expression of the Vsx2-5.3-PRE-Cre transgene was not detected in
the embryonic retina. Weak Cre immunolabeling was first
observed in the central portion of the retina at P3 (Figure 4A–
F). Cre-positive nuclei were highly localized in the developing
neuroblastic layer (NBL), and co-immunolabeled with Vsx2
(Figure 4 A–F). Although the majority of Cre-positive nuclei
resided within the Vsx2-rich inner neuroblastic layer (iNBL)
(Figure 4D–F), a small number of Cre-immunolabeled nuclei were
evident in the apical retina that also immunolabeled for Vsx2
(Figure 4C - arrows). By P6, robust Cre immunolabeling was
present throughout the extent of the central and peripheral retina,
and was predominantly distributed within the outer portion of the
iNBL (Figure 4G–L). Since Vsx2-expressing cells at P3 and P6
may include both proliferating and postmitotic cells, we pulsed P4
mice with the thymidine-analogue CldU to metabolically label
cells in S-phase of the cell cycle in order to determine whether any
of the Cre-immunolabeled cells were mitotically active. Retinas
were fixed for histology at 12-hour intervals after CldU injection.
Only a single example of Cre/CldU co-labeling was captured in
the central retina at 24 hours post injection (not shown; n=3
animals), but by 36 hours, co-labeling of CldU-positive cells with
faint Cre-immunolabeled cells was clearly evident in the central
portion of the retina (Figure 5A–C). By 48 hours after injection,
the population of Cre/CldU double labeled nuclei was highly
enriched in the iNBL (Figure 5D–F).
Having established that the onset of Cre expression is first
detectable between 24 and 48 hours after the last S-phase, we
Figure 2. Vsx2-5.3-PRE-Cre is specifically localized to Vsx2-expressing neurons of the inner nuclear layer in the mature retina. (A–C)
The vast majority of Vsx2-labeled nuclei (A) in the inner nuclear layer (boundaries indicated by broken lines) co-label for Cre (B). Arrowheads in (C)
indicate Vsx2-positive/Cre-negative nuclei outlined in (B). (D–F) Sox9-positive Mu ¨ller glial nuclei (D) do not express Cre. Arrowheads (F) show
examples of Cre-negative/Sox9-positive nuclei outlined in (E). (G–I) Horizontal cells labelled with Calbindin-D28k (G) do not label for Cre (H). Sections
are from .6 week old mice. Scale bar =10 mm.
doi:10.1371/journal.pone.0027145.g002
Table 2. Summary of Vsx2-5.3-PRE-Cre transgenic mouse
lines.
Founder Cre immunolabeling*
Conditional reporter
expression**
2245 22
2690 ++
2695 22
2697 ++
2700 ++
2717 ++
*‘‘+’’ indicates Cre immunolabeling restricted to postmitotic presumptive
bipolar cells and/or mature retinal bipolar cells
**‘‘+’’ indicates reporter expression in the mature retina in bipolar cells and a
subset of photoreceptor cells
doi:10.1371/journal.pone.0027145.t002
Bipolar Cell-Specific Transgenic Mouse
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expression of bipolar fate and differentiation markers. In contrast
to the robust Vsx2-5.3-PRE-Cre expression observed in adult
Cabp5 and PKCa expressing bipolar cells (Figure 3), Cre
immunolabeling appeared before the onset of Cabp5 (Figure 6A–
C) or PKCa (Figure 6D–F) bipolar cell immunolabeling in P3
retinas. Consistent with an absence of co-localization with
Bhlhb5 in adult (Figure3),noco-labelingwasevidentatP3(Figure6
G–I), despite the presence of Cre-positive and Bhlhb5-positive nuclei
located apically of Bhlhb5-expressing, putative amacrine cells
(Figure 6G–I). It is unclear, however, whether the Bhlhb5-labeled
cells residing apical of putativeamacrine cells(e.g. Figure 6G–I, black
arrowheads) label progenitor cells, newly born bipolar cells and/or
amacrine cells.Together,these data indicate that Vsx2-5.3-PRE-Cre is
expressed in newly postmitotic cells and precedes the expression of
mature bipolar cell markers.
Genetic lineage tracing reveals a sub-population of
transient Vsx2-5.3-PRE-Cre expressing cells
Although we were unable to detect Vsx2-5.3-PRE-Cre immu-
nolabeling in the embryonic retina (Figure 1), we next wanted to
explore the possibility that the Vsx2-5.3-PRE-Cre transgene was
expressed either transiently, or at sub-detectable levels during this
period. To examine these possibilities, we utilized a Cre-sensitive
conditional reporter transgenic mouse line. Vsx2-5.3-PRE-Cre
mice were crossed to Gt(ROSA)26Sor
tm9(CAG-tdTomato)Hze mice
(abbreviated as CAG:cond-tdTomato)(Jackson Labs), which contain
a targeted loxP flanked STOP codon which prevents tdTomato
expression in cells not expressing Cre recombinase. TdTomato
expression in adult Vsx2-5.3-PRE-Cre/CAG:cond-tdTomato retinas
largely recapitulated the Cre immunolabeling expression pattern
observed above (Figures 1–3). Specifically, tdTomato-positive
cells were present in the outer tier of the INL, and exhibited
morphological features of bipolar neurons including inner
plexiform layer axon terminal patterning (Figure 7A–C, brack-
eted region). Cre immunolabeling of Vsx2-5.3-PRE-Cre/CAG:cond-
tdTomato retinas revealed that the vast majority of tdTomato cells
in the inner nuclear layer co-labeled with Cre, although examples
of tdTomato-positive/Cre-negative cells were evident (e.g.
outlined cells in Figure 7D–F). At least some of these cells were
recoverin-positive Type 2 OFF bipolar cells (Figure 8A–D),
consistent with the lack of Cre immunolabeling in putative Type
2 bipolar cells (Figure 3J–L). In addition to bipolar cell
expression, a second, infrequent population of tdTomato-
expressing photoreceptor cells was identified in the outer nuclear
layer (Figure 7A–C, arrows). TdTomato-positive photoreceptors
were more commonly observed in the retinal periphery and less
frequently in the central retina (not shown). These cells co-labeled
with the photoreceptor marker recoverin however, consistent
with our findings above, Cre immunolabeling was undetectable in
photoreceptor cells (Figure 8E–H). These genetic lineage tracing
data demonstrate that the Vsx2-5.3-PRE-Cre Cre protein is
functional, and that a Cre-sensitive reporter is able to faithfully
recapitulate the Vsx2-5.3-PRE-Cre Cre immunolabeling pattern in
bipolar cells.
Discussion
Here we describe the development of a novel transgenic tool
that can be used to target postmitotic bipolar interneurons using
Cre recombinase. The Vsx2-5.3-PRE-Cre transgene is expressed in
the majority of Vsx2-expressing bipolar subtypes, but is not
detectable in Vsx2-expressing RPCs, Mu ¨ller glia or non-
neuroretinal structures. Using a conditional reporter approach,
we also detected Vsx2-5.3-PRE-Cre transgene expression in a small
subset of photoreceptors (summarized in Figure 9).
Timing of Vsx2-5.3-PRE-Cre onset
Vsx2-5.3-PRE-Cre immunolabeling is first evident at postnatal
day 3 and represents one of the earliest expressed bipolar cell
markers reported to date. The onset of this expression, combined
with the observation that Cre expression is first detected 24 hours
after the last S-phase is consistent with our finding that bipolar cell
birth in mice begins between postnatal days 1 and 2 (data
not shown). Vsx2-5.3-PRE-Cre expression also precedes the ex-
pression of other bipolar cell-specific markers. For example, Vsx1,
a Vsx2 homologue that regulates terminal gene expression in
Figure 3. Vsx2-5.3-PRE-Cre is expressed in a large subset of
bipolar neurons in the adult retina. Immunolabeling for Cre-
recombinase under control by the Vsx2-5.3-PRE transgene is localized in
nearly all PKCa expressing rod bipolar cells (A–C); a large subset of
CaBp5-expressing Type-III a/b, Type-V ON, or rod bipolar cells (D–F);
mGlur6-lacZ expressing ON bipolar cells (G–I); and a large subset of
PKARIIb-expressing Type-IIb and OFF bipolar neurons (J–L). Bhlhb5
expressing Type-II OFF bipolar cells do not express Vsx2-5.3-PRE-Cre
(M–O). Arrows indicate co-localized cells; solid arrowheads indicate Cre-
only cells; open arrowheads indicate Cre-negative cells. Scale bar (N)
=10mm.
doi:10.1371/journal.pone.0027145.g003
Bipolar Cell-Specific Transgenic Mouse
PLoS ONE | www.plosone.org 5 October 2011 | Volume 6 | Issue 10 | e27145Figure 4. Vsx2-5.3-PRE-Cre is up-regulated postnatally in Vsx2-expressing cells. (A–D) P3 marks the earliest age at which Vsx2-5.3-PRE-Cre
can be detected by immunofluorescence. Strong, Cre-immunolabeled nuclei (A) co-label with Vsx2 (B) within the inner region of the Vsx2-positive
neuroblastic layer (demarcated with dashed lines in C). Inset (D–F) shows high magnification view of examples of Cre/Vsx2 double-labeled nuclei
(arrowheads) within the NBL (box in (C)). (G–I) By P6, a robust up-regulation of Vsx2-5.3-PRE-Cre is evident in Vsx2-expressing cells located
throughout the NBL, although the majority of these cells localize at the apical margin of the NBL. Insets (J–L) show a high magnification view of the
apical NBL. The presence of Cre-negative/Vsx2-positive nuclei located at the apical NBL boundary (arrows) may represent a newly postmitotic (G1)
cell arriving to the Cre-expressing layer.
doi:10.1371/journal.pone.0027145.g004
Figure 5. Vsx2-5.3-PRE-Cre is up-regulated postmitotically, and corresponds to early bipolar cell differentiation. (A–C) Retinas pulsed
with CldU at P4 showed examples of Cre/CldU co-localization (solid arrowheads) at 36 h. This is in contrast to only rare examples detected at 24 h
(not shown). The presence of adjacent, Cre-positive/CldU-negative nuclei (open arrowheads) indicate that the timing of Cre onset of expression is
tightly regulated. (D–F) By 48 h, Cre/CldU cells were clearly evident at high frequency (G–O).
doi:10.1371/journal.pone.0027145.g005
Bipolar Cell-Specific Transgenic Mouse
PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e27145Figure 6 Cre expression precedes expression of the mature bipolar markers PKCa and Cabp5. At postnatal day 3 (P3) Cre-positive nuclei
do not co-localize to Cabp5 (A–C), PKCa (D–F), or with the early bipolar fate marker Bhlhb5 (M–O). Insets (G–I) are high magnification view of Cre-
positive (solid arrowhead) and Cre-negative (open arrowhead) nuclei located apical to the Bhlhb5-positive layer (arrow for example). Scale bar (O)
=20mm.
doi:10.1371/journal.pone.0027145.g006
Figure 7. Genetic fate mapping of the Vsx2-5.3-PRE-Cre transgene using tdTomato conditional reporter mice. Vsx2-5.3-PRE-Cre mice
were crossed with mice containing the Gt(ROSA)26Sor
tm9(CAG-tdTomato)Hze transgene. Offspring in which Cre-mediated recombination events were
present continually express tdTomato in those cells. (A–C) The vast majority of tdTomato-expressing cells in Vsx2-5.3-PRE-Cre/CAG:cond-tdTomato
mice were located in the outer portion of the inner nuclear layer. The morphology of these cells was consistent with that of a bipolar fate, including
terminal lamination in the inner plexiform layer (bracketed region). Immunolabeling for Cre revealed tdTomato-expressing cells in which Cre
expression does not persist in the adult (open arrowheads). A second population of tdTomato expressing cells is also evident in the outer nuclear
layer, and bear morphological resemblance to photoreceptors (arrows).
doi:10.1371/journal.pone.0027145.g007
Bipolar Cell-Specific Transgenic Mouse
PLoS ONE | www.plosone.org 7 October 2011 | Volume 6 | Issue 10 | e27145differentiating Types 2, 3a and 7 bipolar cells [16,27,28], is first
detectable in the retina at postnatal day 5. In addition, expression
of the ON bipolar cell-specific gene mGluR6 as well as the
mGluR6:b-gal transgene reporter is first detectable at postnatal day
6 [26]. These findings suggest that Vsx2-5.3-PRE-Cre transgene
expression defines an early population of undifferentiated bipolar
cells (Figure 9A). Although the existence of an undifferentiated
pan-bipolar cell type has yet to be demonstrated, the Vsx2-5.3-
PRE-Cre transgene could serve as a useful tool for addressing this
possibility.
Comparison of Vsx2-5.3-PRE-Cre and Vsx2 BAC transgenic
mice
In contrast to the postmitotic expression observed in Vsx2-5.3-
PRE-Cre mice, the previously published Vsx2 BAC mice exhibit
mosaic, Cre-mediated reporter expression in multipotent RPCs as
early as E10 [9]. In the postnatal retina, alkaline phosphatase
reporter expression in Vsx2 BAC mice is retained in postmitotic
bipolar and Mu ¨ller cells, and persists in the adult. Further
characterization of Vsx2 upstream regulatory sequences identified
a number of retinal enhancer regions and cis-binding sites for Vsx2
[13,15]. Specifically, alkaline phosphatase reporter mice were
generated using a 2.4 kb or 3.0 kb Vsx2 upstream region, both of
which faithfully recapitulate putative Vsx2 retinal expression [13].
A 22 bp motif residing in the first 500 bp upstream region of Vsx2
was necessary for expression in RPCs, and was identified as a
POU factor (Brn-2 and Tst-1/SCIP) binding domain. The
absence of RPC expression in Vsx2-5.3-PRE-Cre mice is interesting
given that the Vsx2-5.3-PRE-Cre transgene includes the 3.0 kb Vsx2
upstream RPC enhancer region. The lack of RPC expression in
our transgenic mice might be due to repression of the RPC
enhancer caused by the close proximity of the distal 2.5 kb region
Putative Retinal Enhancer (PRE). This region contains the 164 bp
region ,19 kb upstream of the Vsx2 start site that functions as a
bipolar cell specific enhancer but has also been shown to function
as a repressor in photoreceptor cells [15]. The lack of RPC
expression in our transgene may also indicate the existence of a
RPC repressor element within the 3.0 kb and 5.3 kb Vsx2
upstream region. Alternatively, additional missing elements may
be required may be required for RPC expression.
Vsx2-5.3-PRE-Cre as a genetic tool for targeting specified
bipolar cells and photoreceptor-competent precursors
The Vsx2-5.3-PRE-Cre transgene is expressed in the major
bipolar cell sub-classes (i.e. rod bipolar and ON/OFF cone bipolar
cells). Although the absence of Cre immunolabeling in Type 2
OFF cells initially raised the possibility that the Vsx2-5.3-PRE-Cre
transgene is not expressed in Type 2 bipolar cells, constitutive
conditional reporter analysis suggests that this is not the case.
These findings suggest that the Vsx2-5.3-PRE-Cre transgene is
either expressed in an early bipolar cell precursor and subse-
quently down-regulated during Type 2 OFF differentiation, or
that transgene expression in Type 2 bipolar cells is below the level
of detection using immunolabeling (summarized in Figure 9A).
Regardless, our data indicates that the Vsx2-5.3-PRE-Cre transgene
represents a useful tool for targeting most if not all bipolar
cells.
Despite the absence of any detectable photoreceptor Cre
immunolabeling, we occasionally observed tdTomato-positive
photoreceptors. This raises the possibility that the Vsx2-5.3-PRE-
Cre transgene is active in a small population of postmitotic retinal
precursors that are biased, but not fully committed, to becoming
bipolar cells (Figure 9B). Interestingly, tdTomato reporter
expression was not present in retinal cell types other than bipolar
cells and photoreceptor cells. It has previously been shown that
bipolar cell-promoting elements located in within the 1.9 kb
region ,19 kb upstream of Vsx2 repress Vsx2 in rod photorecep-
tors [15]. In addition, Vsx2 has been shown to function in the
postnatal retina as a repressor of rod photoreceptor cell fate [12].
Thus, a failed attempt at bipolar specification would be predicted
to be accompanied by transient Vsx2-5.3-PRE-Cre transgene
Figure 8. Vsx2-5.3-PRE-Cre expression in Type 2 bipolar cells
and photoreceptors of the mature retina indicated by
tdTomato conditional reporter expression. TdTomato fluores-
cence in .6w e e k so l dVsx2-5.3-PRE-Cre mice harbouring the
Gt(ROSA)26Sor
tm9(CAG-tdTomato)Hze transgene did not co-label Type 2
bipolar cells immunolabeled for recoverin (A–D, arrow) or photorecep-
tors that were co-labeled for recoverin (E–H, arrows). The asterisk in (E)
indicates a region of the tdT-fluorescing cell with photoreceptor outer
segment morphology. The dashed lines in (B) and (H) indicate the
boundaries of the inner nuclear layer.
doi:10.1371/journal.pone.0027145.g008
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tion (Figure 9B). The possibility of postmitotic re-specification of
retinal neurons has previously been suggested in dissociation
experiments in which post-mitotic rod precursors were believed to
differentiate into bipolar cells [29]. Vsx2-5.3-PRE-Cre transgenic
mice therefore represent a useful tool to assay (using constitutive
conditional reporters) changes in cell fate within bipolar/
photoreceptor competent precursors in response to experimental
manipulation.
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Figure 9. Summary of Vsx2-5.3-PRE-Cre expression in the developing retina. Although Cre immunolabeling is not evident in proliferating
RPCs, genetic fate mapping identifies Vsx2-5.3-PRE-Cre activity in bipolar and photoreceptor cells. (A) Following bipolar cell specification, Cre
immunolabeling is strongly up-regulated in all bipolar neuron subtypes, with the exception of blhlb5-positive Type 2 OFF cells. TdTomato-positive
photoreceptors could be derived from postmitotic bipolar cell/photoreceptor cell precursors. (B) Alternatively, TdTomato expression may result from
transient low-level Cre expression in photoreceptor cells derived from either RPCs, or from uncommitted bipolar cell precursors that switch their fate
to that of photoreceptor cells.
doi:10.1371/journal.pone.0027145.g009
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